Your browser doesn't support javascript.
loading
Implementation of dihydropyrimidine dehydrogenase deficiency testing in Europe.
de With, M; Sadlon, A; Cecchin, E; Haufroid, V; Thomas, F; Joerger, M; van Schaik, R H N; Mathijssen, R H J; Largiadèr, C R.
Afiliación
  • de With M; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands; Department of Clinical Chemistry, Erasmus University Medical Center, Rotterdam, the Netherlands.
  • Sadlon A; Department of Clinical Chemistry, Inselspital, Bern University Hospital & University of Bern, INO F, Bern, Switzerland.
  • Cecchin E; Department Experimental and Clinical Pharmacology Unit, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Italy.
  • Haufroid V; Louvain Center for Toxicology and Applied Pharmacology (LTAP), Institut de Recherche Expérimentale et Clinique, UCLouvain, Brussels, Belgium; Department of Clinical Chemistry, Cliniques Universitaires Saint-Luc, Brussels, Belgium.
  • Thomas F; Institut Claudius Regaud, IUCT-Oncopole and CRCT, University of Toulouse, Inserm, Toulouse, France.
  • Joerger M; Department of Internal Medicine, Klinik für Medizinische Onkologie & Hämatologie, Kantonsspital, St.Gallen, Switzerland.
  • van Schaik RHN; Department of Clinical Chemistry, Erasmus University Medical Center, Rotterdam, the Netherlands.
  • Mathijssen RHJ; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
  • Largiadèr CR; Department of Clinical Chemistry, Inselspital, Bern University Hospital & University of Bern, INO F, Bern, Switzerland. Electronic address: Carlo.Largiader@insel.ch.
ESMO Open ; 8(2): 101197, 2023 04.
Article en En | MEDLINE | ID: mdl-36989883

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Deficiencia de Dihidropirimidina Deshidrogenasa Tipo de estudio: Diagnostic_studies / Guideline / Observational_studies / Qualitative_research / Risk_factors_studies Límite: Humans País/Región como asunto: Europa Idioma: En Revista: ESMO Open Año: 2023 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Deficiencia de Dihidropirimidina Deshidrogenasa Tipo de estudio: Diagnostic_studies / Guideline / Observational_studies / Qualitative_research / Risk_factors_studies Límite: Humans País/Región como asunto: Europa Idioma: En Revista: ESMO Open Año: 2023 Tipo del documento: Article País de afiliación: Países Bajos